Tesamorelin

Muscle Growth Fat Loss Skin

1–2 mg/day

Injection (SubQ)

Starting from

R320

4 suppliers available - see pricing tab below

View Pricing & Buy

Dosage

1–2 mg/day

Administration

Injection (SubQ)

Category

Growth Hormone

Overview

Tesamorelin is an FDA-approved GHRH analogue studied primarily for reducing visceral adipose tissue. It is one of the most potent growth hormone secretagogues available.

Mechanism of Action

Stimulates GH release from the pituitary. The stabilised structure of Tesamorelin makes it more resistant to enzymatic degradation than native GHRH, extending its activity.

Key Benefits

Potent visceral fat reduction
Increases IGF-1 and lean mass
Well-studied safety profile
FDA-approved history

Side Effects & Safety

Fluid retention, joint pain, and insulin resistance at higher doses. Contraindicated in active malignancies.

Research & Stacking Notes

1–2 mg SubQ daily. Rotate injection sites. Cycle 12–16 weeks.

Stacks Well With

CJC-1295 (DAC)

Growth Hormone

CJC-1295 (DAC) (Water not included) (10 vials - 2mg)

Growth Hormone

AOD-9604 (HGH Frag 176-191)

Growth Hormone

Select your preferred supplier and add to cart. Prices shown include VAT.

Supplier / Lab	Strength / Volume	Price	Availability
UP UPA Labs Australia	2mg 1 Vial	R320	In Stock
KE Keifei Pharmaceuticals Malaysia	2mg 1 Vial	R650	In Stock
NO Noventra Pharma South Africa	10mg 2ml Pen	R1,150	In Stock
VM VMed South Africa	30mg 1 Vial	R1,460	In Stock

All peptides are for research purposes only. Not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before use.